DAN 405
Alternative Names: DAN-405Latest Information Update: 03 Feb 2023
At a glance
- Originator Dantari
- Class Antibodies; Antineoplastics; Benzene derivatives; Drug conjugates; Esters; Immunoconjugates; Taxanes
- Mechanism of Action Microtubule protein inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Prostate cancer
Most Recent Events
- 27 Dec 2022 Preclinical trials in Prostate cancer in USA (Parenteral) on or before December 2022 (Dantari pipeline; December 2022)